Entelos, Inc., a leader in predictive biosimulation technologies for drug discovery, development, and commercialization, announced today that it has expanded its research collaboration with Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) to include multiple therapeutic areas over a five-year term. During the first year of this new agreement, Entelos will dedicate several teams of research engineers and life scientists to support specific projects using its PhysioLab® platforms on behalf of J&JPRD and its affiliates.
